Marken Talks to Pharmaceutical Online About Challenges Facing the Antibody Drug Conjugate (ADC) Market

Tags:

Dan Bell, Marken’s Vice President of Regulatory Compliance and Technical Affairs, talks to Pharmaceutical Online about challenges for the antibody drug conjugate (ADC) market. Read Part One of this two-part series of articles here.

Back to Index